{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T06:15:07Z","timestamp":1751436907688,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>[<jats:sup>123<\/jats:sup>I]ioflupane is a radiopharmaceutical used to visualise the dopaminergic neuron terminals in the striata, to aid in the differential diagnosis among Parkinsonian syndromes (e.g., Parkinson\u2019s disease). However, nearly all of the subjects in the initial development studies of [<jats:sup>123<\/jats:sup>I]ioflupane were Caucasian.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>8 Chinese healthy volunteers (HVs) received a single 111\u00a0MBq\u2009\u00b1\u200910% dose of [<jats:sup>123<\/jats:sup>I]ioflupane and had simultaneous whole-body (head to mid-thigh) anterior and posterior planar scintigraphy scans at 10\u00a0min and 1, 2, 4, 5, 24, and 48\u00a0h. To estimate biodistribution, dosimetry was evaluated for the Cristy\u2013Eckerman female and hermaphrodite male phantoms. Single-photon emission computed tomography (SPECT) images of the brain were acquired at 3 and 6\u00a0h after injection. Blood samples and all voided urine were collected for 48\u00a0h for pharmacokinetic analysis. The results were then compared with those of a similar European study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were strong similarities in uptake and biodistribution between the Chinese and European studies. Excretion was primarily renal, and the values were similar for the first 5\u00a0h but diverged after that, possibly because of differences in subjects\u2019 height and weight. Tracer uptake in regions of interest in the brain was stable over the imaging window of 3 to 6\u00a0h. The difference in mean effective dose for Chinese HVs vs European HVs (0.028\u2009\u00b1\u20090.00448 vs 0.023\u2009\u00b1\u20090.00152\u00a0mSv\/MBq) was not clinically significant. The [<jats:sup>123<\/jats:sup>I]ioflupane was well tolerated<jats:bold>.<\/jats:bold><\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study demonstrated that a single 111\u00a0MBq\u2009\u00b1\u200910% dose of [<jats:sup>123<\/jats:sup>I]ioflupane injection was safe and well tolerated, and the SPECT imaging window of 3 to 6\u00a0h after injection of [<jats:sup>123<\/jats:sup>I]ioflupane was appropriate in Chinese subjects.<\/jats:p>\n                <jats:p><jats:italic>Trial registration number<\/jats:italic> ClinicalTrials.gov: NCT04564092.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13550-023-00978-3","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T18:02:42Z","timestamp":1680890562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety, biodistribution and radiation dosimetry of [123I]ioflupane in healthy Chinese volunteers"],"prefix":"10.1186","volume":"13","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0493-2062","authenticated-orcid":false,"given":"Biao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,7]]},"reference":[{"key":"978_CR1","doi-asserted-by":"publisher","unstructured":"Palermo G, Ceravolo R. Molecular imaging of the dopamine transporter. Cells;2019. https:\/\/doi.org\/10.3390\/cells8080872.","DOI":"10.3390\/cells8080872"},{"issue":"5","key":"978_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/mds.870120502","volume":"12","author":"M Jaber","year":"1997","unstructured":"Jaber M, Jones S, Giros B, Caron MG. The dopamine transporter: a crucial component regulating dopamine transmission. Mov Disord. 1997;12(5):629\u201333. https:\/\/doi.org\/10.1002\/mds.870120502.","journal-title":"Mov Disord"},{"issue":"12","key":"978_CR3","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/mds.10592","volume":"18","author":"V Marshall","year":"2003","unstructured":"Marshall V, Grosset D. Role of dopamine transporter imaging in routine clinical practice. Mov Disord. 2003;18(12):1415\u201323. https:\/\/doi.org\/10.1002\/mds.10592.","journal-title":"Mov Disord"},{"issue":"11","key":"978_CR4","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1136\/jnnp-2012-304436","volume":"84","author":"N Bajaj","year":"2013","unstructured":"Bajaj N, Hauser RA, Grachev ID. Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes. J Neurol Neurosurg Psychiatry. 2013;84(11):1288\u201395. https:\/\/doi.org\/10.1136\/jnnp-2012-304436.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"978_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","volume":"15","author":"TS Benamer","year":"2000","unstructured":"Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord. 2000;15(3):503\u201310.","journal-title":"Mov Disord"},{"issue":"4","key":"978_CR6","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mds.22108","volume":"24","author":"VL Marshall","year":"2009","unstructured":"Marshall VL, Reininger CB, Marquardt M, Patterson J, Hadley DM, Oertel WH, et al. Parkinson\u2019s disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT. Mov Disord. 2009;24(4):500\u20138. https:\/\/doi.org\/10.1002\/mds.22108.","journal-title":"Mov Disord"},{"key":"978_CR7","doi-asserted-by":"publisher","unstructured":"O'Brien JT, Oertel WH, McKeith IG, Grosset DG, Walker Z, Tatsch K et al. Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials. BMJ Open. 2014;4(7):e005122. https:\/\/doi.org\/10.1136\/bmjopen-2014-005122.","DOI":"10.1136\/bmjopen-2014-005122"},{"issue":"1","key":"978_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s002590050190","volume":"25","author":"J Booij","year":"1998","unstructured":"Booij J, Busemann Sokole E, Stabin MG, Janssen AG, de Bruin K, van Royen EA. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters. Eur J Nucl Med. 1998;25(1):24\u201330.","journal-title":"Eur J Nucl Med"},{"issue":"6","key":"978_CR9","first-page":"1023","volume":"46","author":"MG Stabin","year":"2005","unstructured":"Stabin MG, Sparks RB, Crowe E. OLINDA\/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46(6):1023\u20137.","journal-title":"J Nucl Med"},{"key":"978_CR10","unstructured":"Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF et al. MIRD pamphlet no. 16: techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med. 1999;40(2):37s\u201361s."},{"key":"978_CR11","doi-asserted-by":"crossref","unstructured":"Cristy M, Eckerman KF, editors. Specific absorbed fractions of energy at various ages from internal photon sources: 6, Newborn 1987.","DOI":"10.2172\/6202949"},{"issue":"2 Suppl","key":"978_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0146645314558019","volume":"44","author":"S Mattsson","year":"2015","unstructured":"Mattsson S, Johansson L, Leide Svegborn S, Liniecki J, Nosske D, Riklund KA, et al. Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. Ann ICRP. 2015;44(2 Suppl):7\u2013321. https:\/\/doi.org\/10.1177\/0146645314558019.","journal-title":"Ann ICRP"},{"key":"978_CR13","doi-asserted-by":"publisher","unstructured":"Eneanya ND, Yang W, Reese PP. Reconsidering the consequences of using race to estimate kidney function. JAMA. 2019;322(2):113\u20134. https:\/\/doi.org\/10.1001\/jama.2019.5774.","DOI":"10.1001\/jama.2019.5774"},{"issue":"1","key":"978_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.ajkd.2011.02.393","volume":"58","author":"BW Teo","year":"2011","unstructured":"Teo BW, Xu H, Wang D, Li J, Sinha AK, Shuter B, et al. GFR estimating equations in a multiethnic Asian population. Am J Kidney Dis. 2011;58(1):56\u201363. https:\/\/doi.org\/10.1053\/j.ajkd.2011.02.393.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"978_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/jnnp.62.2.133","volume":"62","author":"J Booij","year":"1997","unstructured":"Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AG, et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 1997;62(2):133\u201340. https:\/\/doi.org\/10.1136\/jnnp.62.2.133.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"978_CR16","doi-asserted-by":"publisher","unstructured":"Lee I, Kim JS, Park JY, Byun BH, Park SY, Choi JH et al. Head-to-head comparison of (18) F-FP-CIT and (123) I-FP-CIT for dopamine transporter imaging in patients with Parkinson's disease: a preliminary study. Synapse. 2018;72(7):e22032. https:\/\/doi.org\/10.1002\/syn.22032.","DOI":"10.1002\/syn.22032"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-023-00978-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-023-00978-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-023-00978-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T18:04:20Z","timestamp":1680890660000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-023-00978-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["978"],"URL":"https:\/\/doi.org\/10.1186\/s13550-023-00978-3","relation":{},"ISSN":["2191-219X"],"issn-type":[{"type":"electronic","value":"2191-219X"}],"subject":[],"published":{"date-parts":[[2023,4,7]]},"assertion":[{"value":"30 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Ruijin hospital and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}